Purpose: Despite many national interventions, cervical cancer (CC) rates persist, and in Kentucky (KY), CC incidence rates are on the rise. Additionally, women with disabilities are medically underserved and face more barriers to secondary prevention and healthcare access, have more known risks, and experience more health disparities than women without disabilities. Given that 1 in 4 persons live with a disability in the USA, the purpose of this observational, cross-sectional, quantitative study was to explore the relationship between CC and women with disabilities as evidenced by reproductive cancer discharges from inpatient hospital (IHD) and outpatient services databases (OSD) so as to compare population-specific differences from social determinants of health framework.

Methods: Data from the Kentucky Cabinet for Health and Family Services for 2015 to 2018 were analyzed using MLR. In total, the sample included 584 women with disabilities and 32,773 women without disabilities living in KY. Results: The IHD data analysis found that county of residence (p =.014) and insurance payer (p = .000) were statistically significant and that women on public insurance were 9.6 times as likely to be diagnosed with CC.

Results: of the OSD data analysis found that place of residence (p = .000) and age group (p = .000) were statistically significant and that women aged 40-44 were 9.5 and 2.9 times as likely to have breast cancer and CC respectively.

Conclusion: This study's findings call for; greater attention to strengthening public health surveillance and infrastructure affording visibility of women with disabilities who are underserved, increased proportion of breast and cervical cancer screening at an early age, and increase health access interventions for low resource settings.

Citation Format: Carolyn Akakpo. The Relationship Between Cervical Cancer and Women Living with Disabilities in Kentucky [abstract]. In: Proceedings of the 9th Annual Symposium on Global Cancer Research; Global Cancer Research and Control: Looking Back and Charting a Path Forward; 2021 Mar 10-11. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2021;30(7 Suppl):Abstract nr 108.